Mercer Global Advisors
IBRX icon

Mercer Global Advisors’s ImmunityBio IBRX Stock Holding History

Mercer Global Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.6K Sell
12,741
-826
-6% -$5.65K ﹤0.01% 3034
2025
Q4 		$26.9K Sell
13,567
-3,392
-20% -$7.68K ﹤0.01% 2814
2025
Q3 		$41.7K Sell
16,959
-19,865
-54% -$51.2K ﹤0.01% 2597
2025
Q2 		$97.2K Buy
+36,824
New +$99K ﹤0.01% 2160
2025
Q1 		– Sell
-37,006
Closed -$94.7K – 2205
2024
Q4 		$94.7K Buy
37,006
+8,359
+29% +$34.8K ﹤0.01% 2046
2024
Q3 		$103K Buy
28,647
+8,743
+44% +$40.5K ﹤0.01% 1876
2024
Q2 		$126K Buy
+19,904
New +$131K ﹤0.01% 1854

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return